Phrontline Biopharma: Clinical Trials

2 trials sponsored by Phrontline Biopharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 2
Phase 21Recruiting 1

Follow Phrontline Biopharma: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors.
TJ102 - Ovarian Cancer
Phase 1 / Phase 2RecruitingPhrontline Biopharma1502026-09-292026-11-12
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
TJ101 - Lung Cancer (NSCLC), Prostate Cancer
Phase 1RecruitingPhrontline Biopharma2002025-08-252026-01-12

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Esophageal Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Prostatic Neoplasms (1)

Countries

China (2)  ·  United States (2)